The U.S. Food and Drug Administration (FDA) described the risks of several medications in a new report published in its Drug Safety Newsletter for health care professionals.The move came after the Institute of Medicine (IOM) sharply criticized the FDA in 2006, saying it has “a dysfunctional structure hindering its ability to protect public health.” The Agency has also been criticized for not monitoring drugs after they’re on the market.The report, which fills one of the FDA’s commitments to the IOM after the criticism, details the side effects from the following drugs:
Reuters September 18, 2007